Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BSGM NYSE:ELMD NASDAQ:LNSR NASDAQ:SURG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBSGMBiosig Technologies$4.78-9.3%$5.92$0.23▼$14.11$150.19M1.65700,896 shs538,849 shsELMDElectromed$24.77+19.9%$19.65$13.74▼$35.56$207.72M0.3883,857 shs295,300 shsLNSRLENSAR$12.19-3.2%$12.86$3.80▼$17.31$145.55M0.5127,598 shs60,595 shsSURGSurgePays$2.57+3.2%$2.86$1.05▼$3.47$52.51M0.44718,819 shs80,371 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBSGMBiosig Technologies-0.57%+9.56%+10.02%-9.91%+1,077.65%ELMDElectromed+2.28%+7.83%+9.78%+1.62%+36.37%LNSRLENSAR-0.55%+0.72%-3.52%-7.29%+176.70%SURGSurgePays0.00%+9.69%-15.31%-18.63%+33.16%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBSGMBiosig Technologies2.41 of 5 stars3.50.00.00.02.71.70.6ELMDElectromed2.3178 of 5 stars3.73.00.00.02.01.70.0LNSRLENSAR1.0446 of 5 stars2.01.00.00.03.22.50.0SURGSurgePays3.0299 of 5 stars3.55.00.00.01.61.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBSGMBiosig Technologies 3.00Buy$10.00109.21% UpsideELMDElectromed 3.33Buy$36.2546.35% UpsideLNSRLENSAR 2.00Hold$15.0023.05% UpsideSURGSurgePays 3.00Buy$9.00250.19% UpsideCurrent Analyst Ratings BreakdownLatest SURG, ELMD, BSGM, and LNSR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/27/2025ELMDElectromedLoop CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$36.008/27/2025ELMDElectromedRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$29.00 ➝ $35.008/27/2025ELMDElectromedLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$36.007/22/2025ELMDElectromedRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$29.007/21/2025ELMDElectromedRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy6/16/2025SURGSurgePaysAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.75 ➝ $9.006/6/2025BSGMBiosig TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$2.50 ➝ $10.00(Data available from 8/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBSGMBiosig Technologies$40K3,754.69N/AN/A($0.11) per share-43.45ELMDElectromed$61.44M3.38$0.60 per share41.36$5.10 per share4.86LNSRLENSAR$53.49M2.72N/AN/A($1.93) per share-6.32SURGSurgePays$36.46M1.44N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBSGMBiosig Technologies-$10.33MN/A0.00N/AN/AN/A-5,336.99%-90.03%11/13/2025 (Estimated)ELMDElectromed$5.15M$0.7933.03∞N/A11.34%15.71%13.37%N/ALNSRLENSAR-$31.40M-$4.21N/A∞N/A-84.49%-737.30%-72.60%11/6/2025 (Estimated)SURGSurgePays-$45.73M-$2.49N/AN/AN/A-133.85%-333.87%-195.36%11/11/2025 (Estimated)Latest SURG, ELMD, BSGM, and LNSR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/15/2025Q2 2025BSGMBiosig Technologies-$0.04-$0.74-$0.70-$0.74N/AN/A8/13/2025Q2 2025SURGSurgePays-$0.31-$0.36-$0.05-$0.36$16.14 million$11.52 million8/7/2025Q2 2025LNSRLENSAR-$0.0750-$0.15-$0.0750-$0.15$16.55 million$11.36 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBSGMBiosig TechnologiesN/AN/AN/AN/AN/AELMDElectromedN/AN/AN/AN/AN/ALNSRLENSARN/AN/AN/AN/AN/ASURGSurgePaysN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBSGMBiosig TechnologiesN/A0.030.03ELMDElectromedN/A5.104.74LNSRLENSARN/A1.520.88SURGSurgePays101.871.110.84Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBSGMBiosig Technologies7.16%ELMDElectromed40.82%LNSRLENSAR40.15%SURGSurgePays6.94%Insider OwnershipCompanyInsider OwnershipBSGMBiosig Technologies24.80%ELMDElectromed14.00%LNSRLENSAR66.00%SURGSurgePays30.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBSGMBiosig Technologies5031.42 million23.63 millionNo DataELMDElectromed1608.39 million7.36 millionOptionableLNSRLENSAR11011.94 million4.06 millionOptionableSURGSurgePays4020.43 million14.20 millionOptionableSURG, ELMD, BSGM, and LNSR HeadlinesRecent News About These CompaniesPhone-in-a-Box Prepaid Service SmartphonesAugust 25 at 6:52 PM | csnews.comCAnalysts Have Lowered Expectations For SurgePays, Inc. (NASDAQ:SURG) After Its Latest ResultsAugust 16, 2025 | finance.yahoo.comSurgePays (NASDAQ:SURG) Cut to "Sell" at Wall Street ZenAugust 16, 2025 | americanbankingnews.comSurgePays (NASDAQ:SURG) Releases Earnings Results, Misses Expectations By $0.05 EPSAugust 15, 2025 | marketbeat.comSurgePays Second Quarter 2025 Earnings: Misses ExpectationsAugust 15, 2025 | finance.yahoo.comSurgePays sees 2025 revenue $75M-$90M vs. $15.09M in 2024August 15, 2025 | msn.comSurgePays Reports Growth and Sets Ambitious Revenue TargetsAugust 14, 2025 | msn.comSurgePays, Inc. (NASDAQ:SURG) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | insidermonkey.comSurgePays, Inc. (SURG) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | seekingalpha.comSurgePays, Inc. (SURG) Reports Q2 Loss, Lags Revenue EstimatesAugust 13, 2025 | zacks.comSurgePays Accelerates Growth Across All Business Verticals; Reports Q2 2025 Results and Issues Revenue Guidance of $75M to $90M in 2025 and $225M to $240M in 2026August 13, 2025 | prnewswire.comSurgePays (NASDAQ:SURG) Shares Pass Above Two Hundred Day Moving Average - What's Next?August 10, 2025 | marketbeat.comSurgePays (SURG) Expected to Announce Earnings on TuesdayAugust 6, 2025 | marketbeat.comSurgePays to Host Second Quarter 2025 Financial Results Conference Call on Wednesday, August 13August 5, 2025 | prnewswire.comSURG | SurgePays Inc. Annual Income Statement | MarketWatchJuly 31, 2025 | marketwatch.comSurgePays CEO Brian Cox to Participate in Fireside Chat Hosted by Water Tower ResearchJuly 23, 2025 | prnewswire.comSurgePays to Feature New "Phone-in-a-Box" Prepaid Service and ClearLine Point-of-Sale Marketing Platform at Upcoming All Wireless and Prepaid ExpoJuly 21, 2025 | prnewswire.comSurgePays Launches New PrePaid Service Smartphones Designed For Convenience Stores And Non-Wireless Retail ChannelsJuly 3, 2025 | twice.comTGPOPlus+ Shareholder UpdateJune 30, 2025 | accessnewswire.comASurgePays launches prepaid phone-in-a-box service for convenience storesJune 27, 2025 | investing.comSurgePays Launches New Prepaid Service, "Phone-in-a-Box," Designed for Convenience Stores and Non-Wireless Retail ChannelsJune 26, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAn Atomic Sized Surge Is Brewing for NuScale Power Stock PriceBy Thomas Hughes | August 11, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025The Case for Buying NVIDIA Stock Ahead of the Robotics SurgeBy Thomas Hughes | August 20, 2025Archer's Flight Milestones & Defense Wins Excite Wall Street By Jeffrey Neal Johnson | August 20, 2025Microsoft Blasts Past Earnings—What’s Next for MSFT?By Chris Markoch | July 31, 2025SURG, ELMD, BSGM, and LNSR Company DescriptionsBiosig Technologies NASDAQ:BSGM$4.78 -0.49 (-9.30%) Closing price 04:00 PM EasternExtended Trading$4.88 +0.10 (+2.09%) As of 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.Electromed NYSE:ELMD$24.77 +4.11 (+19.89%) Closing price 04:00 PM EasternExtended Trading$24.71 -0.06 (-0.24%) As of 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.LENSAR NASDAQ:LNSR$12.19 -0.40 (-3.18%) Closing price 04:00 PM EasternExtended Trading$12.20 +0.01 (+0.08%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.SurgePays NASDAQ:SURG$2.57 +0.08 (+3.21%) Closing price 04:00 PM EasternExtended Trading$2.60 +0.03 (+1.32%) As of 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas As Bitcoin Falls and Ethereum Rallies, Coinbase Stock Comes Back Williams-Sonoma Q2 Results Prove Its Buy-and-Hold Quality Okta: Market Comes to a Boil, Explosive Upside Is Possible MongoDB Roars Back to Life: It’s Not Too Late to Buy More Vertical Aerospace: An Analyst's Roadmap to a Potential Re-Rating AEHR Spikes 36% on Hyperscaler Order—Investors Should Take Notice From Debt to Liftoff: EchoStar's $23 Billion Catalyst Buffett’s Wisdom Could Spell Trouble for Palantir Shorts Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.